Science Explorer Back to mapMap

Most cited papers from Susan Thompson Buffett Foundation

What are the most cited papers from Susan Thompson Buffett Foundation?

The most cited paper from Susan Thompson Buffett Foundation is "Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology" (Al B. Benson et al., 2021), with 1,789 citations. Next come "Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology" (1,772) and "Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology" (1,628).

Showing 50 of 60 papers. Every paper with more than 346 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Al B. Benson et al. · Journal of the National Comprehensive Cancer Network Mar 2021 1,789
2 Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology Jaffer A. Ajani et al. · Journal of the National Comprehensive Cancer Network Open access Feb 2022 1,772
3 Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology William John Gradishar et al. · Journal of the National Comprehensive Cancer Network Apr 2020 1,628
4 Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology James Lloyd Mohler et al. · Journal of the National Comprehensive Cancer Network Open access May 2019 1,580
5 Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology David S. Ettinger et al. · Journal of the National Comprehensive Cancer Network May 2022 1,453
6 Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology David G. Pfister et al. · Journal of the National Comprehensive Cancer Network Jul 2020 1,406
7 Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Margaret A. Tempero et al. · Journal of the National Comprehensive Cancer Network Open access Apr 2021 1,340
8 Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology Margaret von Mehren et al. · Journal of the National Comprehensive Cancer Network Open access Jul 2022 1,188
9 Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Mary B. Daly et al. · Journal of the National Comprehensive Cancer Network Open access 6 Jan 2021 1,130
10 Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology Jaffer A. Ajani et al. · Journal of the National Comprehensive Cancer Network Open access Jul 2019 1,106
11 Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Al B. Benson et al. · Journal of the National Comprehensive Cancer Network May 2021 1,068
12 Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology Margaret A. Tempero et al. · Journal of the National Comprehensive Cancer Network Aug 2017 1,046
13 NCCN Guidelines Insights: Colon Cancer, Version 2.2018 Al B. Benson et al. · Journal of the National Comprehensive Cancer Network Open access Apr 2018 1,045
14 NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021 David S. Ettinger et al. · Journal of the National Comprehensive Cancer Network Open access Mar 2021 1,017
15 NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020 David S. Ettinger et al. · Journal of the National Comprehensive Cancer Network Open access Dec 2019 1,009
16 Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology William John Gradishar et al. · Journal of the National Comprehensive Cancer Network Jun 2022 981
17 Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology Michelle B. Riba et al. · Journal of the National Comprehensive Cancer Network Open access Oct 2019 892
18 Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology Al B. Benson et al. · Journal of the National Comprehensive Cancer Network Oct 2022 863
19 Non–Small Cell Lung Cancer, Version 4.2024 Gregory J. Riely et al. · Journal of the National Comprehensive Cancer Network May 2024 838
20 NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016 David S. Ettinger et al. · Journal of the National Comprehensive Cancer Network Open access Mar 2016 739
21 Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology Deborah Kay Armstrong et al. · Journal of the National Comprehensive Cancer Network Open access Feb 2021 737
22 Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology Robert John Motzer et al. · Journal of the National Comprehensive Cancer Network Open access 2022 676
23 NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017 Mary B. Daly et al. · Journal of the National Comprehensive Cancer Network Open access 31 Dec 2016 664
24 Prostate Cancer, Version 1.2016 James Lloyd Mohler et al. · Journal of the National Comprehensive Cancer Network 2016 657
25 Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology Margaret R O'Donnell et al. · Journal of the National Comprehensive Cancer Network Open access Jul 2017 656
26 Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology William John Gradishar et al. · Journal of the National Comprehensive Cancer Network Jul 2024 653
27 NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018 Alexander Dimitrios Colevas et al. · Journal of the National Comprehensive Cancer Network Open access May 2018 642
28 Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology Thomas W. Flaig et al. · Journal of the National Comprehensive Cancer Network Open access Mar 2020 638
29 Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology Douglas E. Wood et al. · Journal of the National Comprehensive Cancer Network Open access Apr 2018 633
30 Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology Robert A. Swarm et al. · Journal of the National Comprehensive Cancer Network Open access Aug 2019 626
31 Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Manisha H. Shah et al. · Journal of the National Comprehensive Cancer Network Jul 2021 624
32 Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology Edward Matthew Schaeffer et al. · Journal of the National Comprehensive Cancer Network Open access Oct 2023 604
33 Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology Burt Nabors et al. · Journal of the National Comprehensive Cancer Network Open access Nov 2020 581
34 Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology Jaffer A. Ajani et al. · Journal of the National Comprehensive Cancer Network Open access Apr 2023 570
35 Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology John A. Thompson et al. · Journal of the National Comprehensive Cancer Network Open access 11 Mar 2019 567
36 NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022 Jimmy J. Caudell et al. · Journal of the National Comprehensive Cancer Network Mar 2022 549
37 NCCN Guidelines Insights: Breast Cancer, Version 1.2017 William John Gradishar et al. · Journal of the National Comprehensive Cancer Network Open access Apr 2017 545
38 NCCN Guidelines Insights: Prostate Cancer, Version 1.2021 Edward Matthew Schaeffer et al. · Journal of the National Comprehensive Cancer Network Open access Feb 2021 532
39 Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology Robert I. Haddad et al. · Journal of the National Comprehensive Cancer Network Open access Aug 2022 525
40 NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020 Mary Beryl Daly et al. · Journal of the National Comprehensive Cancer Network Open access Apr 2020 516
41 NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023 David S. Ettinger et al. · Journal of the National Comprehensive Cancer Network Open access Apr 2023 509
42 NCCN Guidelines Insights: Rectal Cancer, Version 6.2020 Al B. Benson et al. · Journal of the National Comprehensive Cancer Network Open access Jul 2020 508
43 Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology Apar Kishor Ganti et al. · Journal of the National Comprehensive Cancer Network Open access Dec 2021 493
44 NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020 John A. Thompson et al. · Journal of the National Comprehensive Cancer Network Open access Mar 2020 493
45 NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018 David S. Ettinger et al. · Journal of the National Comprehensive Cancer Network Open access Jul 2018 472
46 NCCN Guidelines® Insights: Breast Cancer, Version 4.2023 William John Gradishar et al. · Journal of the National Comprehensive Cancer Network Open access Jun 2023 461
47 Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology Timothy D. Gilligan et al. · Journal of the National Comprehensive Cancer Network Dec 2019 454
48 Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology Daniel G. Coit et al. · Journal of the National Comprehensive Cancer Network Apr 2019 440
49 Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology John A. Thompson et al. · Journal of the National Comprehensive Cancer Network Apr 2022 429
50 Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology Martin S. Tallman et al. · Journal of the National Comprehensive Cancer Network Jun 2019 427

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.